Principal Financial Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16M | Buy |
422,776
+146,484
| +53% | +$464K | ﹤0.01% | 1911 |
|
|
2025
Q4 | $1.02M | Buy |
276,292
+86,236
| +45% | +$279K | ﹤0.01% | 1951 |
|
|
2025
Q3 | $504K | Sell |
190,056
-203,234
| -52% | -$393K | ﹤0.01% | 2045 |
|
|
2025
Q2 | $387K | Buy |
393,290
+380,034
| +2,867% | +$381K | ﹤0.01% | 2030 |
|
|
2025
Q1 | $19.1K | Buy |
13,256
+1,157
| +10% | +$2.13K | ﹤0.01% | 2151 |
|
|
2024
Q4 | $26.6K | Sell |
12,099
-3,245
| -21% | -$7.57K | ﹤0.01% | 2190 |
|
|
2024
Q3 | $25.3K | Sell |
15,344
-5,086
| -25% | -$10.3K | ﹤0.01% | 2205 |
|
|
2024
Q2 | $45.4K | Sell |
20,430
-8,721
| -30% | -$20.5K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $78.1K | Sell |
29,151
-4,482
| -13% | -$10.9K | ﹤0.01% | 2300 |
|
|
2023
Q4 | $101K | Sell |
33,633
-803
| -2% | -$1.04K | ﹤0.01% | 2273 |
|
|
2023
Q3 | $33.7K | Buy |
34,436
+2,898
| +9% | +$4.19K | ﹤0.01% | 2376 |
|
|
2023
Q2 | $43.8K | Buy |
31,538
+12,248
| +63% | +$17.1K | ﹤0.01% | 2369 |
|
|
2023
Q1 | $30.7K | Sell |
19,290
-1,448
| -7% | -$7.47K | ﹤0.01% | 2404 |
|
|
2022
Q4 | $129K | Buy |
20,738
+3,882
| +23% | +$27.8K | ﹤0.01% | 2260 |
|
|
2022
Q3 | $113K | Sell |
16,856
-142
| -0.8% | -$975 | ﹤0.01% | 2312 |
|
|
2022
Q2 | $108K | Buy |
16,998
+6,511
| +62% | +$36.9K | ﹤0.01% | 2383 |
|
|
2022
Q1 | $49K | Buy |
+10,487
| New | +$45K | ﹤0.01% | 2487 |
|
|
2020
Q4 | – | Sell |
-5,559
| Closed | -$207K | – | 2428 |
|
|
2020
Q3 | $207K | Sell |
5,559
-4,551
| -45% | -$180K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $518K | Buy |
+10,110
| New | +$423K | ﹤0.01% | 1960 |
|
|
2020
Q1 | – | Sell |
-3,966
| Closed | -$236K | – | 2214 |
|
|
2019
Q4 | $236K | Buy |
+3,966
| New | +$178K | ﹤0.01% | 2099 |
|
|
2018
Q2 | – | Sell |
-4,618
| Closed | -$334K | – | 2283 |
|
|
2018
Q1 | $334K | Buy |
4,618
+449
| +11% | +$33K | ﹤0.01% | 2004 |
|
|
2017
Q4 | $274K | Buy |
+4,169
| New | +$224K | ﹤0.01% | 2064 |
|
Other funds holding ESPR
WA
TSC
O
VCM
